iBio, Inc. Common Stock (IBIO)
iBio, Inc. Common Stock (IBIO) has a 17-report earnings history dating back to May 17, 2021. Its average absolute post-earnings move is ±5.41%, and 17.6% of those reactions were positive. Its largest post-earnings gain was +2.14% (May 13, 2024) and its largest decline was -34.98% (Sep 27, 2022). The next earnings report is predicted for 2026-11-18 (approximate).
Earnings reactions
How IBIO moved on each past earnings report.
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±5.41%
Positive %
17.6%
Negative %
82.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 28, 2026 | ☀ PRE | -3.2% | open_in_new |
| May 12, 2026 | ☽ POST | -2.8% | — |
| Feb 10, 2026 | ☽ POST | -3.08% | open_in_new |
| Nov 12, 2025 | ☽ POST | -7.63% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±5.41%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| ARS | 20260904 | open_in_new SEC.gov |
| DEF 14A | 20260904 | open_in_new SEC.gov |
| 10-K | 20260828 | open_in_new SEC.gov |
| 8-K | 20260828 | open_in_new SEC.gov |
| PRE 14A | 20260820 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260813 | open_in_new SEC.gov |
| 3 | 20260804 | open_in_new SEC.gov |
Frequently asked about IBIO earnings
When does iBio, Inc. Common Stock report earnings next? expand_more
iBio, Inc. Common Stock (IBIO)'s next earnings date is approximate for 2026-11-18. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IBIO stock move after earnings? expand_more
Over 17 reports, IBIO has moved an average of ±5.41% the session after earnings, closing higher 17.6% of the time.
What was IBIO's biggest post-earnings move? expand_more
IBIO's largest post-earnings gain on record was +2.14% on May 13, 2024, and its largest decline was -34.98% on Sep 27, 2022.
Where can I find iBio, Inc. Common Stock's SEC filings? expand_more
All of iBio, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right